INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
Right to try laws and requirements in Tennessee. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Have Enacted State Right to Try Laws | have state RTT laws | Tenn. Code Ann. §§ 63-6-301 to -309“63-6-301. This part shall be known and may be cited as the "Phil Timp-Amanda Wilcox Right to Try Act".” | Link | 2026-10-09 | high |
| Enacted Right to Try Laws Before Federal Law | 2015 | 2015 Tenn. Pub. Acts ch. 376 (HB 143/SB 811)“HB0143 Date Effective date(s) 07/01/2015 05/12/2015 Pub. Ch. 376 05/12/2015 Signed by Governor.”Note: Stored 2016 is wrong. Signed May 2015, Pub. Ch. 376, effective July 1, 2015; the public chapter (SECTION 3) says 'This act shall take effect July 1, 2015'. | Link | 2026-10-09 | high |
| Require Individualized Manufacturer Approval for RTT | require individualized approval | Tenn. Code Ann. §§ 63-6-1301 et seq.; 2025 Tenn. Pub. Acts ch. 45 (SB 282/HB 192)“63-6-1301. This part is known and may be cited as the "Individualized lnvestigational Treatment Act."”Note: Stored false is wrong. 2025 Pub. Ch. 45 (SB 282/HB 192), effective 07/01/2025 per TN bill index, adds individualized investigational treatment (patient-specific, genetic-profile-based; includes ASOs and neoantigen vaccines) for life-threatening or severely debilitating illness. Goldwater's Apr 2026 list of 17 RTT 2.0 states also includes Tennessee. ('lnvestigational' typo is in the OCR'd PDF text.) | Link | 2026-10-09 | high |
| Provide Manufacturer Liability Protection Under RTT | provide liability shield | Tenn. Code Ann. § 63-6-308(1)“This part does not create a private cause of action against a manufacturer of an investigational drug, biological product, or device or against any other person or entity involved in the care of an eligible patient”Note: Stored false is wrong. 'No private cause of action' clause (not an immunity), qualified: applies 'if the manufacturer or other person or entity is complying in good faith with the terms of this part and has exercised reasonable care.' The required informed consent must also include 'A release of liability relative to the treating physician, licensed healthcare providers, hospital, and manufacturer' (§ 63-6-302(4)(E)). Text checked as enacted in 2015; later amendments not reviewed. | Link | 2026-10-09 | high |
| Require Insurer Coverage of Investigational Treatments | do not require coverage | Tenn. Code Ann. § 63-6-304(b)“A health plan, third-party administrator, or governmental agency may, but is not required to, provide coverage for the cost of an investigational drug, biological product, or device” | Link | 2026-10-09 | high |
View full Tennessee profile (all layers) · Report an error on this page